Search results (1331)
« Back to PublicationsDiscovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs.
O'Byrne S. et al, (2019), Blood, 134, 1059 - 1071
Improving the diagnosis and classification of Ph-negative myeloproliferative neoplasms through deep phenotyping
Sirinukunwattana K. et al, (2019), bioRxiv
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
GOODING S. et al, (2019), Nature Communications
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K. et al, (2019), Eur J Cancer, 118, 10 - 34
Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma.
Djebbari F. et al, (2019), Br J Haematol, 186, e191 - e195
Phase 3 International Trial of Adjuvant Whole Brain Radiotherapy (WBRT) or Observation (OBS) Following Local Treatment of 1-3 Melanoma Brain Metastases (MBMs)
Fogarty GB. et al, (2019), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105, S139 - S140
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes.
de Santiago I. et al, (2019), Int J Cancer, 145, 1125 - 1137
Adjuvant whole brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicentre, randomized phase 3 trial
MIDDLETON M. et al, (2019), Journal of Clinical Oncology
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.
Kesavan M. et al, (2019), Curr Hematol Malig Rep, 14, 207 - 218
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
Scarisbrick JJ. et al, (2019), Br J Dermatol, 181, 350 - 357
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.
Banerji U. et al, (2019), Lancet Oncol, 20, 1124 - 1135
New challenges in psycho-oncology: Using drug development methodology to improve survivorship and supportive care intervention trials.
Howells L. et al, (2019), Psychooncology, 28, 1362 - 1366
The T cell architecture of pancreatic ductal adenocarcinoma.
Sivakumar S. et al, (2019), Annals of oncology : official journal of the European Society for Medical Oncology, 30 Suppl 4, iv64 - iv64
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma.
Andtbacka RHI. et al, (2019), J Immunother Cancer, 7
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC).
Lebbe C. et al, (2019), Eur J Cancer, 114, 117 - 127
IMMUNOTHERAPY-RELATED GASTRITIS IN A TERTIARY ONCOLOGY CENTRE
Cheung V. et al, (2019), GUT, 68, A147 - A148
Germline selection shapes human mitochondrial DNA diversity.
Wei W. et al, (2019), Science (New York, N.Y.), 364